BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10894822)

  • 1. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study.
    Schmidt R; Schmidt H; Fazekas F; Kapeller P; Roob G; Lechner A; Kostner GM; Hartung HP
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1811-6. PubMed ID: 10894822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
    Schmidt H; Schmidt R; Niederkorn K; Gradert A; Schumacher M; Watzinger N; Hartung HP; Kostner GM
    Stroke; 1998 Oct; 29(10):2043-8. PubMed ID: 9756579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs.
    Gnasso A; Motti C; Irace C; Di Gennaro I; Pujia A; Leto E; Ciamei M; Crivaro A; Bernardini S; Federici G; Cortese C
    Atherosclerosis; 2002 Oct; 164(2):289-95. PubMed ID: 12204800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
    Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
    Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
    Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
    Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults.
    Voetsch B; Benke KS; Damasceno BP; Siqueira LH; Loscalzo J
    Stroke; 2002 Jun; 33(6):1459-64. PubMed ID: 12052975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
    Malin R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Pasanen M; Oja P; Bond G; Koivula T; Lehtimäki T
    Metabolism; 2001 Sep; 50(9):1095-101. PubMed ID: 11555845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
    Shenhar-Tsarfaty S; Waiskopf N; Ofek K; Shopin L; Usher S; Berliner S; Shapira I; Bornstein NM; Ritov Y; Soreq H; Ben Assayag E
    Eur J Neurol; 2013 Jun; 20(6):891-8. PubMed ID: 23305304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities.
    Schmidt R; Schmidt H; Fazekas F; Launer LJ; Niederkorn K; Kapeller P; Lechner A; Kostner GM
    Hypertension; 2001 Jul; 38(1):110-5. PubMed ID: 11463770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
    Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
    Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
    Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
    Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
    Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study.
    Schmidt R; Fazekas F; Kapeller P; Schmidt H; Hartung HP
    Neurology; 1999 Jul; 53(1):132-9. PubMed ID: 10408549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions.
    Hadjigeorgiou GM; Malizos K; Dardiotis E; Aggelakis K; Dardioti M; Zibis A; Dimitroulias A; Scarmeas N; Tsezou A; Karantanas A
    J Orthop Res; 2007 Aug; 25(8):1087-93. PubMed ID: 17469180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
    Hasselwander O; Savage DA; McMaster D; Loughrey CM; McNamee PT; Middleton D; Nicholls DP; Maxwell AP; Young IS
    Kidney Int; 1999 Jul; 56(1):289-98. PubMed ID: 10411705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral white matter lesions, retinopathy, and incident clinical stroke.
    Wong TY; Klein R; Sharrett AR; Couper DJ; Klein BE; Liao DP; Hubbard LD; Mosley TH;
    JAMA; 2002 Jul; 288(1):67-74. PubMed ID: 12090864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.